[Cronkhite-Canada syndrome: an acquired, potentially reversible polyposis].

Abstract

Cronkhite-Canada syndrome is an infrequent, nonadenomatous, acquired polyposis that is associated with ectodermic alterations. The etiopathogenesis and optimal therapeutic management are unknown. We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. The polypoid lesions of Cronkhite-Canada syndrome can be reversed with medical treatment. Consequently, the natural history of the disease can be modified and its prognosis improved.

• Authors: Eva Marín Serrano, Pablo Guillén Mariscal, José Pérez-Requena, Paloma Rendón Unceta
• Journal: Gastroenterologia y hepatologia (Gastroenterol Hepatol) Vol. 29 Issue 10 Pg. 619-21 (Dec 2006) ISSN: 0210-5705 [Print] Spain
• Vernacular Title: Síndrome de Cronkhite-Canada: una poliposis adquirida y potencialmente reversible.
• PMID: 17198639 (Publication Type: Case Reports, English Abstract, Journal Article)

Topics

• Humans
• Intestinal Polyposis (diagnosis, drug therapy)
• Male
• Middle Aged
• Remission Induction